Bladder Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for bladder cancer. To learn more about a study, choose from the list below.

Showing 17 trials

Title	Investigator
A Genotype-Phenotype Urothelial Cancer Study [Protocol 09-025]	Bajorin, Dean, MD
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy [Protocol 10-031]	Kollmeier, Marisa, MD
A Phase I Study of a Neo-Urinary Conduit in Patients Requiring Urinary Diversion After Bladder Removal [Protocol 11-073]	Bochner, Bernard, MD
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations [Protocol 13-131]	Voss, Martin, MD
A Phase I Study of INK128 (MLN0128) in Patients with Advanced Kidney, Bladder, or Endometrial Cancer [Protocol 13-118]	Voss, Martin, MD
A Phase I Trial of Gemcitabine and Split-Dose Cisplatin plus Everolimus in Patients with Advanced Urothelial Cancer [Protocol 10-106]	Bajorin, Dean, MD
A Phase I/II Study of Everolimus and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Non-Muscle-Invasive Bladder Cancer [Protocol 10-165]	Dalbagni, Guido, MD
A Phase II Study of BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium [Protocol 11-060]	Bajorin, Dean, MD
A Phase II Study of DN24-02 as Adjuvant Therapy in Patients with High-Risk HER2-positive Urothelial Cancers [Protocol 11-163]	Bajorin, Dean, MD
A Phase II Study of Gemcitabine and Pazopanib in Previously Untreated Patients with Advanced Urothelial Cancers Who Cannot Receive Cisplatin [Protocol 11-191]	Bajorin, Dean, MD
A Phase II Study of Gemcitabine, Carboplatin, and Panitumumab Given Before Surgery in Patients with Muscle-Invasive Bladder Cancer [Protocol 10-103]	Bajorin, Dean, MD
A Phase II Study of Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer [Protocol 12-071]	Bajorin, Dean, MD
A Phase II Study of Neratinib in Patients with Solid Tumors Containing Mutated HER2 [Protocol 13-140]	Solit, David, MD
A Phase II Study of SNX-5422 in Patients with Select Advanced HER2 Cancers [Protocol 13-112]	Voss, Martin, MD
A Phase III Study Comparing Standard versus Extended Pelvic Lymph Node Removal During Bladder Cancer Surgery [Protocol 12-049]	Bochner, Bernard, MD
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma [Protocol 12-119]	Rosenberg, Jonathan, MD
A Prospective Study of Quality of Life in Patients with Invasive Bladder Cancer [Protocol 08-076]	Bochner, Bernard, MD

Related Topics

Clinical Trials: How Clinical Trials Work

Recommended Links

American Cancer Society: What You Need to Know About Clinical Trials

National Cancer Institute: Questions to Ask About a Clinical Trials Web Site

Cancer.Net from ASCO: About Clinical Trials

Clinical Trials Home Page (Cancer.gov)